Karen Daily

4PUBLICATIONS
26CO-AUTHORS
Molecular targetsCancer therapy (excl. chemotherapy and radiation therapy)Cancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|Dec 03, 2024
Phase II Trial of the PARP Inhibitor, Niraparib, in BAP1 and Other DNA Damage Response Pathway-Deficient Neoplasms.

Thomas J George, Ji-Hyun Lee, David L DeRemer

|Dec 15, 2021
BRE12-158: A Postneoadjuvant, Randomized Phase II Trial of Personalized Therapy Versus Treatment of Physician's Choice for Patients With Residual Triple-Negative Breast Cancer.

Bryan P Schneider, Guanglong Jiang, Tarah J Ballinger

|Apr 08, 2021
Acinic Cell Carcinoma of the Breast: Report of a Case With Immunohistochemical and Next-Generation Sequencing Studies.

Kaitlin D Weaver, James Isom, Ashwini Esnakula

Pageof 1